A phase II Study of the global dose and schedule of capecitabine in Japanese patients with metastatic colorectal cancer.
暂无分享,去创建一个
I. Hyodo | Y. Arai | K. Nakagawa | K. Shirao | T. Doi | H. Takiuchi | T. Tamura | K. Yamaguchi | K. Hatake | H. Mishima | S. Takemiya